SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-24-015448
Filing Date
2024-03-27
Accepted
2024-03-27 07:02:43
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20018253x2_defa14a.htm DEFA14A 16834
2 ny20018253x2_nc1.jpg GRAPHIC 1215687
3 ny20018253x2_nc2.jpg GRAPHIC 1357230
  Complete submission text file 0001140361-24-015448.txt   3557580
Mailing Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158 (415) 660-5320
Nurix Therapeutics, Inc. (Filer) CIK: 0001549595 (see all company filings)

IRS No.: 270838048 | State of Incorp.: DE | Fiscal Year End: 1130
Type: DEFA14A | Act: 34 | File No.: 001-39398 | Film No.: 24785742
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)